+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | Tumor Suppressor ARF (CDKN2A) |
Clonality | Polyclonal |
Reactivity | Human |
Tested Applications | ELISA, WB, IHC, IF/ICC |
Host | Rabbit |
Recommended dilutions | WB: 1/500 - 1/3000, IHC: 1/50 - 1/100, IF/ICC: 1/100 - 1/500, ELISA: 1/5000. Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against synthesized peptide derived from human p14 ARF (CDKN2A). |
Isotype | IgG |
Form | Liquid |
Purification | Purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | Q8N726 (UniProt, ExPASy) |
UniProt Secondary AC | D3DRK2, Q13195, Q13399, Q16360, Q7KZR9 |
UniProt Entry Name | ARF_HUMAN |
Gene Symbol | CDKN2A |
GeneID | 1029 |
OMIM | 600160 155601 |
HGNC | 1787 |
KEGG | hsa:1029 |
Ensembl | ENSG00000147889 |
String | 9606.ENSP00000418915 |
Sequence | CQPLPRRPGHDDGQRPSGGA |
Buffer | PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02% sodium azide, 50% glycerol. |
Specificity | p14 ARF Antibody detects endogenous levels of total p14 ARF protein. |
Concentration | 1 mg/ml |
Availability | Shipped within 5-10 working days. |
Note | This product is for research use only. |